Article Versions Notes

Lee C, Mu W, Chen XJ, Chan MSM, Chen Z, Yeung SF, Chan HHY, Chow ST, Ko BCB, Chan DW, et al. Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer. Cancers. 2025; 17(13):2246. https://doi.org/10.3390/cancers17132246

Lee, Carol, Weixue Mu, Xi July Chen, Mandy Sze Man Chan, Zhishan Chen, Sai Fung Yeung, Helen Hoi Yin Chan, Sin Ting Chow, Ben Chi Bun Ko, David Wai Chan, and et al. 2025. "Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer" Cancers 17, no. 13: 2246. https://doi.org/10.3390/cancers17132246

Lee, C., Mu, W., Chen, X. J., Chan, M. S. M., Chen, Z., Yeung, S. F., Chan, H. H. Y., Chow, S. T., Ko, B. C. B., Chan, D. W., Cho, W. C., Lui, V. W. Y., & Tsui, S. K. W. (2025). Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer. Cancers, 17(13), 2246. https://doi.org/10.3390/cancers17132246